Clinical Trial: Study of INV-202 in Patients With Obesity and Metabolic Syndrome
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Obesity
Study Type: INTERVENTIONAL
Official Title: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Pharmacokinetics of 3 Doses of INV-202 With an Optional Open-Label Extension in Patients With Obesity and Met
Brief Summary:
The study is designed to assess the efficacy, safety, tolerability, and transformation within the human body of INV-202 investigational drug in the treatment of adult participants with obesity and metabolic syndrome.
Read more